Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Giannopoulos · SciRah

Researcher profile · Semantic Scholar

K. Giannopoulos

Share profile

K. Giannopoulos — researcher profile on SciRah

h-index: 34
Works: 170
Citations: 3,982

Most-cited papers

The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
J. Tabarkiewicz, K. Pogoda, A. Karczmarczyk, P. Pożarowski +1 more
2015Archivum Immunologiae et Therapiae Experimentalis230 citations Open access
Semantic Scholar
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
C. Tam, Jennifer R. Brown, B. Kahl, P. Ghia +27 more
2022The Lancet Oncology205 citations Open access
Semantic Scholar
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
A. Agathangelidis, A. Chatzidimitriou, Katerina Gemenetzi, V. Giudicelli +79 more
2020Blood116 citations Open access
Semantic Scholar
B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies
K. Bojarczuk, M. Siernicka, M. Dwojak, M. Bobrowicz +8 more
2014Leukemia66 citations
Semantic Scholar
Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy
D. Dytfeld, M. Luczak, T. Wróbel, L. Usnarska-Zubkiewicz +19 more
2016OncoTarget63 citations Open access
Semantic Scholar
Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia
K. Giannopoulos
2019Journal of Clinical Medicine62 citations Open access
Semantic Scholar
Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from the Phase 3 Unity-CLL Study
J. Gribben, W. Jurczak, R. Jacobs, S. Grosicki +23 more
2020Blood56 citations Open access
Semantic Scholar
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
D. Dytfeld, T. Wróbel, K. Jamroziak, T. Kubicki +29 more
2023The Lancet Oncology54 citations Open access
Semantic Scholar
HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.
M. Bobrowicz, M. Dwojak, B. Pyrzynska, Joanna Stachura +29 more
2017Blood49 citations Open access
Semantic Scholar
Laccase purified from Cerrena unicolor exerts antitumor activity against leukemic cells
A. Matuszewska, M. Karp, M. Jaszek, G. Janusz +5 more
2016Oncology Letters42 citations Open access
Semantic Scholar
Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia
M. Grzywnowicz, A. Karczmarczyk, K. Skórka, M. Zając +4 more
2015Acta Haematologica40 citations Open access
Semantic Scholar
Mosunetuzumab Monotherapy Continues to Demonstrate Promising Efficacy and Durable Complete Responses in Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
A. Olszewski, A. Avigdor, S. Babu, I. Levi +13 more
2022Blood37 citations Open access
Semantic Scholar
Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)
E. Iskierka-Jażdżewska, M. Hus, K. Giannopoulos, E. Mądro +18 more
2017Leukemia and Lymphoma37 citations
Semantic Scholar
Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL—another piece in the puzzle
A. Filip, A. Grenda, Sylwia Popek, D. Koczkodaj +6 more
2016Annals of Hematology34 citations Open access
Semantic Scholar
The Application of CAR-T Cells in Haematological Malignancies
K. Skórka, Katarzyna Ostapińska, Aneta Malesa, K. Giannopoulos
2020Archivum Immunologiae et Therapiae Experimentalis30 citations Open access
Semantic Scholar
A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry
T. Sacha, J. Góra-Tybor, M. Szarejko, G. Bober +12 more
2017American journal of hematology/oncology28 citations Open access
Semantic Scholar
Suppressed Programmed Death 1 Expression on CD4+ and CD8+ T Cells in Psoriatic Patients
J. Bartosińska, E. Zakrzewska, Dorota Raczkiewicz, J. Purkot +5 more
2017Mediators of Inflammation27 citations Open access
Semantic Scholar
Decreased blood CD4+PD-1+ and CD8+PD-1+ T cells in psoriatic patients with and without arthritis
J. Bartosińska, E. Zakrzewska, J. Purkot, Anna Michalak-Stoma +4 more
2018Advances in Dermatology and Allergology26 citations Open access
Semantic Scholar
CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL).
B. Kahl, K. Giannopoulos, W. Jurczak, M. Šimkovič +25 more
2022Clinical Lymphoma, Myeloma & Leukemia25 citations
Semantic Scholar
Expression of CD274 (PD‐L1) is associated with unfavourable recurrent mutations in AML
M. Zając, J. Zaleska, A. Dolnik, L. Bullinger +1 more
2018British Journal of Haematology25 citations Open access
Semantic Scholar
Response to anti‐SARS‐CoV‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
J. Zaleska, P. Kwaśnik, M. Paziewska, J. Purkot +30 more
2022International Journal of Cancer24 citations Open access
Semantic Scholar
DNA methylation signature in blood does not predict calendar age in patients with chronic lymphocytic leukemia but may alert to the presence of disease.
M. Spólnicka, Renata Zbieć-Piekarska, M. Karp, M. Machnicki +9 more
2018Forensic Science International: Genetics24 citations
Semantic Scholar
Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma.
Aleksander Salomon-Perzyński, A. Walter-Croneck, L. Usnarska-Zubkiewicz, D. Dytfeld +15 more
2019Advances in Medical Sciences23 citations
Semantic Scholar
The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia
M. Grzywnowicz, L. Karabon, A. Karczmarczyk, M. Zając +9 more
2015Leukemia and Lymphoma23 citations
Semantic Scholar
Differential expression of programmed death 1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis and psoriatic arthritis.
J. Bartosińska, E. Zakrzewska, A. Król, Dorota Raczkiewicz +5 more
2017Polish Archives of Internal Medicine20 citations Open access
Semantic Scholar
Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance
E. Wawrzyniak, A. Kotkowska, J. Błoński, M. Siemieniuk-Ryś +4 more
2014European Journal of Haematology20 citations
Semantic Scholar
PD1/PD1L pathway, HLA-G and T regulatory cells as new markers of immunosuppression in cancers.
P. Własiuk, Maciej Putowski, K. Giannopoulos
2016Postępy Higieny i Medycyny Doświadczalnej19 citations Open access
Semantic Scholar
P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW-UP OF THE SEQUOIA STUDY
T. Munir, M. Shadman, T. Robak, Jennifer R. Brown +31 more
2023HemaSphere18 citations Open access
Semantic Scholar
Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group
N. Grząśko, R. Hájek, M. Hus, S. Chocholska +12 more
2017Leukemia and Lymphoma18 citations Open access
Semantic Scholar
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study
B. Puła, E. Iskierka-Jażdżewska, M. Długosz-Danecka, A. Szymczyk +24 more
2020Anticancer Research16 citations Open access
Semantic Scholar
Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma
J. Bartosińska, J. Purkot, A. Karczmarczyk, Michał Chojnacki +12 more
2021Cells13 citations Open access
Semantic Scholar
Optogenetics in cancer drug discovery
M. Kiełbus, Jakub Czapiński, Adrian Odrzywolski, G. Stasiak +6 more
2018Expert Opinion on Drug Discovery13 citations
Semantic Scholar
Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations—NOTCH1, SF3B1, MYD88, BIRC3
Maciej Putowski, K. Giannopoulos
2021Journal of Clinical Medicine12 citations Open access
Semantic Scholar
Treatment-Free Remission—A New Aim in the Treatment of Chronic Myeloid Leukemia
P. Kwaśnik, K. Giannopoulos
2021Journal of Personalized Medicine12 citations Open access
Semantic Scholar
ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT‐NAïVE (TN) CLL/SLL: EXTENDED FOLLOW‐UP OF THE SEQUOIA STUDY
M. Shadman, T. Munir, T. Roback, J. Brown +31 more
2023Hematological Oncology11 citations Open access
Semantic Scholar
Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia
M. Masternak, B. Puła, Joanna Knap, A. Waszczuk-Gajda +14 more
2020Cancer Management and Research11 citations Open access
Semantic Scholar
Accumulation of CD5+CD19+ B lymphocytes expressing PD-1 and PD-1L in hypertrophied pharyngeal tonsils
P. Własiuk, A. Niedzielski, K. Skórka, A. Karczmarczyk +5 more
2015Clinical and Experimental Medicine (Testo stampato)11 citations Open access
Semantic Scholar
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
E. Hawkes, T. Phillips, L. Budde, A. Santoro +14 more
2021Targeted oncology10 citations Open access
Semantic Scholar
Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
Maciej Putowski, M. Podgórniak, Marta Piróg, Joanna Knap +8 more
2017Polish Archives of Internal Medicine10 citations Open access
Semantic Scholar
The expression of selected molecular markers of immune tolerance in psoriatic patients.
J. Bartosińska, J. Purkot, M. Kowal, Anna Michalak-Stoma +3 more
2018Advances in Clinical and Experimental Medicine9 citations Open access
Semantic Scholar
The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
J. Tabarkiewicz, K. Pogoda, A. Karczmarczyk, P. Pożarowski +1 more
2015Archivum Immunologiae et Therapiae Experimentalis9 citations Open access
Semantic Scholar
Cereblon expression predicts clinical response in chronic lymphocytic leukemia treated with a thalidomide/fludarabine regimen
K. Jamroziak, J. Szemraj, T. Robak, A. Tukiendorf +1 more
2015Leukemia and Lymphoma9 citations
Semantic Scholar
Molnupiravir is effective in patients with haematological malignancies
Ł. Bołkun, B. Puła, A. Kołkowska-Leśniak, M. Morawska +13 more
2023International Journal of Cancer8 citations
Semantic Scholar
Aberrant Expression of TLR2, TLR7, TLR9, Splicing Variants of TLR4 and MYD88 in Chronic Lymphocytic Leukemia Patients
K. Skórka, P. Własiuk, A. Karczmarczyk, K. Giannopoulos
2021Journal of Clinical Medicine8 citations Open access
Semantic Scholar
Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells
Justyna Chlebowska-Tuz, Olga Sokolowska, P. Gaj, M. Lazniewski +19 more
2018Haematologica8 citations Open access
Semantic Scholar
Efficacy and Safety of Ublituximab in Combination with Umbralisib (U2) in Patients with Chronic Lymphocytic Leukemia (CLL) By Treatment Status: A Sub-Analysis of the Phase 3 Unity-CLL Study
R. Jacobs, W. Jurczak, I. Flinn, S. Grosicki +24 more
2021Blood7 citations Open access
Semantic Scholar
Cytotoxic activity of valproic acid on primary chronic lymphocytic leukemia cells.
M. Karp, Kamila Kosior, A. Karczmarczyk, M. Zając +6 more
2015Advances in Clinical and Experimental Medicine7 citations Open access
Semantic Scholar
Current status and achievements of Polish haemato-oncology
S. Giebel, G. Basak, M. Bieniaszewska, T. Czerw +26 more
2021Acta Haematologica Polonica6 citations Open access
Semantic Scholar
The Selective Bruton Tyrosine Kinase (BTK) Inhibitor TG-1701 As Monotherapy and in Combination with Ublituximab and Umbralisib (U2) in Patients with B-Cell Malignancies
Che-Ah Y. Chan, W. Jurczak, M. Lasica, T. Wróbel +10 more
2021Blood6 citations Open access
Semantic Scholar
Analysis of circulating soluble programmed death 1 (PD-1), neuropilin 1 (NRP-1) and human leukocyte antigen-G (HLA-G) in psoriatic patients
J. Bartosińska, Anna Michalak-Stoma, M. Kowal, Dorota Raczkiewicz +3 more
2018Advances in Dermatology and Allergology6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Karczmarczyk×10
Invite
A. Karczmarczyk — researcher profile on SciRah
W. Jurczak×9
Invite
W. Jurczak — researcher profile on SciRah
T. Robak×9
Invite
T. Robak — researcher profile on SciRah
K. Jamroziak×9
Invite
K. Jamroziak — researcher profile on SciRah

×8

Invite

T. Wróbel — researcher profile on SciRah

Invite

J. Zaleska — researcher profile on SciRah

Invite

S. Grosicki — researcher profile on SciRah

Invite

J. Purkot — researcher profile on SciRah

Invite

P. Własiuk — researcher profile on SciRah

L. Usnarska-Zubkiewicz×6

Invite

L. Usnarska-Zubkiewicz — researcher profile on SciRah

Invite

M. Zając — researcher profile on SciRah

J. Bartosińska×6

Invite

J. Bartosińska — researcher profile on SciRah